-
-
Rakel D. Journaling: The effects of disclosure on health. Altern Med Alert 2004;7(1):8-11.
-
Schnieder CD, Morgan SE. Tai chi and fall prevention in the elderly. Altern Med Alert 2004;7(1):1-4.
-
When should placebos be used in clinical research? Can subjects with a medical condition be asked to consent to withdraw from their current medications and take an experimental medication with the 50/50 chance that what they actually receive will be no medication at all?
-
The Genetic Modification Clinical Research Information System (GeMCRIS), a web-based data system designed to assist researchers and others involved in human gene therapy studies, manages information about science and safety of clinical trials in this field. Three years in development, the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) jointly launched GeMCRIS at the end of March.
-
-
A once-a-day dose of a valacyclovir reduces the rate of transmission of genital herpes (HSV-2) from an infected partner to an uninfected susceptible partner, according to a new study. The study group included 1484 immunocompetent, heterosexual, monogamous couples in which 1 partner had symptomatic genital HSV-2 and the other was susceptible to HSV-2.
-
For clinical trials administrators and investigators who desire best practices in human subjects protection, there can be no better place to start than with research staff education. Education and training of research staff and investigators traditionally was provided in the form of a mentoring program in which a junior person learned from a senior person, says Ruth Fischbach, PhD, MPE, director of the Center for Bioethics at Columbia University in New York City.
-
-